| 34.96 Delayed Data As of 4:00pm ET |  +0.195 / +0.56%Today’s Change | 27.75 Today|||52-Week Range 46.33 | -3.32% Year-to-Date |
| Xencor Inc (XNCR) Q3 2019 Earnings Call Transcript Nov 05 / MotleyFool.com - Paid Partner Content |
| Previous close | 34.77 |
| Today’s open | 34.45 |
| Day’s range | 34.12 - 35.42 |
| Volume | 174,687 |
| Average volume (3 months) | 335,052 |
| Market cap | $1.9B |
| Earnings growth (last year) | -24.31% |
| Earnings growth (this year) | +132.48% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +13.70% |
| P/E ratio | 59.3 |
| Price/Sales | 48.04 |
| Price/Book | 3.59 |
| Today’s change | Today’s % change | |
|---|---|---|
| TLRYTilray Inc | -0.64 | -2.97% |
| HRTXHeron Therapeutics I... | -0.62 | -2.99% |
| MNTAMomenta Pharmaceutic... | +0.01 | +0.06% |
| EIDXEidos Therapeutics I... | -1.09 | -2.52% |
| Next reporting date | February 25, 2020 |
| EPS forecast (this quarter) | -$0.44 |
| Annual revenue (last year) | $40.6M |
| Annual profit (last year) | -$70.4M |
| Net profit margin | -173.41% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Monrovia, California |
